Skip to Main Content

Plenary Session II

Tuesday, May 1 - 9:35 am - 1:00 pm

Moderator(s): Frederick G. Barker II, MD, FAANS; Alex B. Valadka, MD, FAANS

11:32 am - 11:42 am

615. Evaluation of Durable Response Rate in the Post-Resection Setting and Association with Survival in Patients with Recurrent High Grade Glioma who Received Vocimagene Amiretroprepvec and 5-Fluorocytosine Treatment

Bob S. Carter, MD, PhD, FAANS

Journal of Neuro-Oncology Award